Blood clots are a phenomenon that people fear. Once thrombosis forms, it is easy to cause various diseases, among which pulmonary embolism is a serious disease caused by thrombosis. Currently, enoxparin sodium injection is a drug to help prevent thrombosis and treat disease.

　　Enoxaparin sodium injection as the main economic component of enoxaparin sodium, is a low molecular heparin sodium. Enoxparin sodium injection is a sodium salt with amino group passing through glucan fragment obtained from sulfuric acid obtained from heparin extracted from porcine small intestinal mucosa through benzyl esterification and alkali degradation.

　　Enoxaparin injection to prevent thrombosis. Adults at high risk of blood clots were given 40 milligrams of enoxaparin 12 hours before surgery, followed by a subcutaneous injection of 40 milligrams every 24 hours. Enoxaparin can also be used for cardiopulmonary bypass in hemodialysis to prevent thrombosis. For thrombosis.

　　For prevention and treatment, subcutaneous injection of low molecular weight heparin and intravascular cardiopulmonary bypass should be used when performing hemodialysis. Intramuscular injection of enoxaparin is prohibited.

　　When using enoxparin sodium injection, it should be noted that different low-molecular-weight heparin should not be used as a substitute for one another due to the difference in molecular weight, anti-oxA activity and dose. Special attention and observation should be paid to the use of the corresponding products. Patients with a history of heparin-induced thrombocytopenia should be administered with caution. Enoxparin sodium injection should be closely monitored.

　　Patients should use enoxaparin injection only under the guidance of a physician, not without permission, and keep drug development away from children. Kowloon is Heparins Manufacturer, welcome to consult and understand